FDAFDA · Food and drugs·Recall number D-0560-2022
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Published February 23, 2022 · Recall initiated: January 14, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- MOXIFLOXACIN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- USA Nationwide
- UPC
- 0365862840035
- Lot
- Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.